NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-07-23
Reading DBD? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on improving profitability and revenue growth. The current thesis state is stable, supported by recent earnings beats and a commitment to financial improvement.
The market appears to have priced in a justified valuation, reflecting a premium compared to peers. However, there is an expectations gap, indicating that some growth may already be anticipated.
Management's focus on enhancing profitability and revenue growth is showing progress, with recent improvements in net income and operating income. The near-term risk of missing earnings is low, but recent industry trends could impact performance.
The key forward scenarios include potential guidance cuts, which could negatively affect sentiment, and favorable conditions such as Fed rate cuts or strong performance from sector leaders like SAP and CRM, which could support DBD's growth.
Overall, DBD's fundamentals are on track, but external factors will play a significant role in its performance over the next few years. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improvement. There are no new threats to the thesis. The overall outlook remains positive.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Meeting or exceeding this target shows the company is on track with its revenue growth goals.
Confirms:Q2 revenue growth of 6% YoY or better confirms strong execution of growth strategies.
Disproves:Q2 revenue growth is below 6% YoY. This shows possible problems in reaching growth goals.
Why it matters: High free cash flow helps the company invest and give money back to shareholders.
Confirms:Free cash flow is over $20 million. This shows strong cash generation is ongoing.
Disproves:Free cash flow falls below $20 million. This raises worries about cash generation.
Why it matters: If sector revenue growth falls, it may impact Diebold Nixdorf's performance. This is a broader market signal.
Confirms one read:Sector revenue growth drops below its median.
Confirms the other:Sector revenue growth stays above its median.
Why it matters: Free cash flow is crucial for funding growth. A drop below $255 million could signal trouble.
Confirms:Free cash flow guidance reported below $255 million.
Disproves:Free cash flow guidance reported at or above $255 million.
Why it matters: Higher operating income shows better efficiency. It also means better cost management. This helps with making more money.
Confirms:Operating income exceeds $35M in Q2.
Disproves:Operating income falls below $30M in Q2.
Why it matters: An increase in net income would show that the company is moving towards profitability. This is crucial for long-term growth.
Confirms:Net income exceeds $7M in Q2.
Disproves:Net income remains below $5M in Q2.
Why it matters: A drop in free cash flow may raise worries about financial health and funding operations.
Confirms:Free cash flow in Q2 falls below $20 million.
Disproves:Free cash flow in Q2 exceeds $20 million.
Why it matters: A higher margin shows the company is making more money and working better. This can help investor feelings.
Confirms:Adjusted EBITDA margin expands beyond 13% in Q2.
Disproves:Adjusted EBITDA margin remains at or below 13% in Q2.
Why it matters: Finishing the share buyback program may show trust in the company's finances. It could help the share price.
Confirms:Company finishes the $200 million share buyback program by Q3.
Disproves:Company does not complete the share repurchase program by Q3.
Why it matters: The adjusted EBITDA margin shows how much money a company makes. If it drops below 13%, it could cause worry.
Confirms:The EBITDA margin is under 13%.
Disproves:Adjusted EBITDA margin is at or above 13%.
Why it matters: A better EBITDA margin means the company is making more money and working well.
Confirms:Adjusted EBITDA margin is higher than Q1 2026. This shows good cost management.
Disproves:Adjusted EBITDA margin goes down or stays the same. This suggests problems with cost control.
Why it matters: News on share buybacks shows how much management trusts the company's finances.
Confirms one read:Big share buybacks announced show strong financial health.
Confirms the other:No news or a pause in buybacks may show caution in managing finances.
